Cargando…

Editorial: Pharmaceutical policy, impact and health outcomes

Detalles Bibliográficos
Autores principales:	Kwon, Hye-Young, Godman, Brian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971951/ https://www.ncbi.nlm.nih.gov/pubmed/36865922 http://dx.doi.org/10.3389/fphar.2023.1150055

Ejemplares similares

Introduction of managed entry agreements in Korea: Problem, policy, and politics
por: Kim, Hyungmin, et al.
Publicado: (2023)

Editorial: Emerging Markets’ Health and Pharmaceutical Sectors at the Dawn of a Potential Global Financial Crisis of early 2020s
por: Jakovljevic, Mihajlo, et al.
Publicado: (2022)

A Review of the Evidence on Attitudes, Perceived Impacts and Motivational Factors for European Member State Collaboration for Pricing and Reimbursement of Medicines: Time for the EEA Member States to Apply Their Experience and Expertise in Evidence-Based Decision Making to Their Current Pharmaceutical Policy Challenges
por: Vella Bonanno, Patricia, et al.
Publicado: (2021)

Editorial: Shaping with data: Using pharmacoepidemiology to shape pharmaceutical policy and clinical decision-making
por: Tadrous, Mina, et al.
Publicado: (2022)

Availability and Affordability of Drugs With a Conditional Approval by the European Medicines Agency; Comparison of Korea With Other Countries and the Implications
por: Kwon, Hye-Young, et al.
Publicado: (2018)

Policies to Encourage the Use of Biosimilars in European Countries and Their Potential Impact on Pharmaceutical Expenditure
por: Vogler, Sabine, et al.
Publicado: (2021)

Editorial: New Horizons in Health-Promoting Technologies: From Development to Rational Use
por: Lopes, Luciane Cruz, et al.
Publicado: (2020)

Formulary Management Activities and Practice Implications Among Public Sector Hospital Pharmaceutical and Therapeutics Committees in a South African Province
por: Matlala, Moliehi, et al.
Publicado: (2020)

Editorial: Women in drugs outcomes research and policies: 2021
por: Alves da Costa, Filipa, et al.
Publicado: (2022)

Editorial: Protein nanoparticles: characterization and pharmaceutical application
por: Gagliardi, Agnese, et al.
Publicado: (2023)

Pharmaceutical Strategy for Europe: Reflections on Public Health-Driven Drug Development, Regulation, and Policies
por: Garattini, Silvio, et al.
Publicado: (2021)

Editorial: Rising stars in drugs outcomes research and policies: 2021
por: Lins, Robert L., et al.
Publicado: (2022)

Editorial: Potential of Extracellular Matrix Molecules in Pharmaceutical Development
por: Zheng, Zhong, et al.
Publicado: (2021)

Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries?
por: Kim, Yujeong, et al.
Publicado: (2020)

Editorial: Emerging talents in pharmacology: Drugs outcomes research and policies 2022
por: Linger, Rachel M. A., et al.
Publicado: (2023)

Editorial: New Horizons in Health-Promoting: From Methods to Implementation Science
por: Barberato-Filho, Silvio, et al.
Publicado: (2022)

Editorial: Grand Challenges in Pharmaceutical Medicine: Competencies and Ethics in Medicines Development
por: Silva, Honorio, et al.
Publicado: (2021)

Pan-Canadian Pharmaceutical Alliance (pCPA): Timelines Analysis and Policy Implications
por: Salek, Sam M., et al.
Publicado: (2019)

Editorial: Evidence for Assessing Drug Safety and Drug Use in Older People
por: Lopes, Luciane Cruz, et al.
Publicado: (2022)

Editorial: Model-informed decision making in the preclinical stages of pharmaceutical research and development
por: Li, Rui, et al.
Publicado: (2023)

Editorial: Role of Health Economic Data in Policy Making and Reimbursement of New Medical Technologies
por: Jakovljevic, Mihajlo, et al.
Publicado: (2017)

Editorial: Impact of anesthetics on cancer behavior and outcome
por: Lin, Jui-An, et al.
Publicado: (2022)

Editorial: Medication safety and interventions to reduce patient harm in low- and middle-income countries
por: Mahmoud, Mansour Adam, et al.
Publicado: (2023)

Perceptions, Expectations, and Experience of Physicians About Pharmacists and Pharmaceutical Care Services in Pakistan: Findings and Implications
por: Hayat, Khezar, et al.
Publicado: (2021)

Editorial: The practical implication of clinical pharmacokinetics in drug development, pharmaceutical analysis, and clinical research
por: Khan, Abad, et al.
Publicado: (2023)

Editorial: Opioids in the time of the COVID-19 pandemic: from cellular mechanisms to public health policy
por: John, Scott, et al.
Publicado: (2023)

Editorial: Pharmaceutical Innovation After World War II: From Rational Drug Discovery to Biopharmaceuticals
por: Zarros, Apostolos, et al.
Publicado: (2019)

Editorial: Protection and healing in the digestive system and other tissues: Novel factors, mechanisms, and pharmaceutical targets
por: Brzozowski, Thomas, et al.
Publicado: (2022)

Editorial: Hepatic insulin resistance and related obesity: highlighting the ameliorative role of nutraceuticals, dietary intervention, and pharmaceuticals
por: Ramadan, Nehal M., et al.
Publicado: (2023)

Changing Characteristics of Pharmaceutical Prices in China Under Centralized Procurement Policy: A Multi-Intervention Interrupted Time Series
por: Long, Hongfei, et al.
Publicado: (2022)

Performance of a pharmaceutical services regionalization strategy policy in Minas Gerais, Brazil: Pre-post analysis from ERAF project
por: Luz, Tatiana Chama Borges, et al.
Publicado: (2022)

Evaluation of the impact of pharmaceutical trainings and tools on the proper use of medicines in pediatrics
por: Charles, F., et al.
Publicado: (2023)

Impact of a Collaborative Pharmaceutical Care Service for Patients With Parkinson’s Disease
por: Yi, Zhan-Miao, et al.
Publicado: (2022)

The Impact of Reimbursement Practices on the Pharmaceutical Market for Off-Patent Medicines in Slovakia
por: Tesar, Tomas, et al.
Publicado: (2021)

Policies to Enhance Prescribing Efficiency in Europe: Findings and Future Implications
por: Godman, Brian, et al.
Publicado: (2011)

The impact of key monitoring policy on the usage of policy-related drugs in Hubei Province, China
por: Wen, Xiaotong, et al.
Publicado: (2023)

Situation, Impacts, and Future Challenges of Tobacco Control Policies for Youth: An Explorative Systematic Policy Review
por: Ranabhat, Chhabi Lal, et al.
Publicado: (2019)

Antimicrobial Medicines Consumption in Eastern Europeand Central Asia – An Updated Cross-National Study and Assessment of QuantitativeMetrics for Policy Action
por: Robertson, Jane, et al.
Publicado: (2019)

Potential to Enhance the Prescribing of Generic Drugs in Patients with Mental Health Problems in Austria; Implications for the Future
por: Godman, Brian, et al.
Publicado: (2013)

Mapping of Current Obstacles for Rationalizing Use of Medicines (CORUM) in Europe: Current Situation and Potential Solutions
por: Gad, Mohamed, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ba8i8o50usfra1g6uahlk3aqdd